1-20 of 73
Edus H. Warren
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Acalabrutinib in Combination with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory B-Cell Lymphoma: A Phase I/II Study of Safety, Efficacy and Immune Correlative Analysis

Christina Poh, Victor A Chow, Ryan C Lynch, Chaitra S Ujjani, Mazyar Shadman, Brian G Till, Vikram Raghunathan, Edus H Warren, Jordan Gauthier, Stephen D Smith, Taran Gujral, Chihiro Morishima, Qian Wu, Jenna M Voutsinas, Amy Sperling, Joshua Dizon, David G Maloney, Ajay K Gopal
Journal: Blood
Blood (2023) 142 (Supplement 1): 2129.
https://doi.org/10.1182/blood-2023-183034
Published: 2023
Journal Articles

Durable Remissions in Advanced Stage and Molecularly High Risk Untreated Classic Hodgkin Lymphoma with Pembrolizumab + AVD

Ryan C Lynch, Stefan K. Alig, Chaitra S Ujjani, Christina Poh, Edus H Warren, Stephen D Smith, Mazyar Shadman, Brian G Till, Vikram Raghunathan, Yolanda D Tseng, Susan Ottemiller, Bonnie Joy, Melissa Mary Fessel, Hongyan Du, Jacquelin Vandermeer, Alyssa Kelly, Heather Rasmussen, Jenna M Voutsinas, Qian Wu, Ash A. Alizadeh, Ajay K Gopal
Journal: Blood
Blood (2023) 142 (Supplement 1): 4429.
https://doi.org/10.1182/blood-2023-179547
Published: 2023
Journal Articles

Brentuximab Vedotin in Combination with Nivolumab in CD30+ Malignancies Refractory to Brentuximab Vedotin

Christina Poh, Ryan C Lynch, Edus H Warren, Chaitra S Ujjani, Stephen D Smith, Michi M Shinohara, Jonathan R Fromm, Xinyi Fan, Jenna M Voutsinas, Qian Wu, Laura Naylor, Heather Rasmussen, Ajay K Gopal
Journal: Blood
Blood (2023) 142 (Supplement 1): 3060.
https://doi.org/10.1182/blood-2023-178279
Published: 2023
Journal Articles

A Phase 1 Study of Subcutaneous Rituximab Hyaluronidase Combined with Local Standard-of-Care Chemotherapy for the Treatment of Diffuse Large B-Cell Lymphoma in Uganda

Henry Ddugnu, Kelvin Mubiru, Scott V Adams, Jacqueline Asea, Joyce Kambugu, Rosemary Namagembe, Prossy Namuli, Jackson Orem, Camille Puronen, Thomas S. Uldrick, Edus H Warren, Manoj P Menon
Journal: Blood
Blood (2023) 142 (Supplement 1): 4467.
https://doi.org/10.1182/blood-2023-189875
Published: 2023
Journal Articles

Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphoma

Clinical Trials & Observations
Ryan C. Lynch, Chaitra S. Ujjani, Christina Poh, Edus H. Warren, Stephen D. Smith, Mazyar Shadman, Brian Till, Vikram M. Raghunathan, Stefan Alig, Ash A. Alizadeh, Avanti Gulhane, Delphine L. Chen, Yolanda Tseng, Hilary Coye, Megan Shelby, Susan Ottemiller, Sarith Keo, Kaitlin Verni, Hongyan Du, Jacquelin Vandermeer, Ashley Gaston, Heather Rasmussen, Paul Martin, Edmond Marzbani, Jenna Voutsinas, Ajay K. Gopal
Journal: Blood
Blood (2023) 141 (21): 2576–2586.
https://doi.org/10.1182/blood.2022019254
Published: 2023
Includes: Supplemental data
Journal Articles

Clinical Outcome and Treatment-Related Mortality in Patients with Acute Myeloid Leukemia Treated at the Uganda Cancer Institute

Clement Dove Okello, Soheil Meshinchi, Katherine Tarlock, Edus H. Warren, Andrea M.H. Towlerton, Henry Ddungu, Yusuf Mulumba, Fadhil Geriga, Jackson Orem, Joyce K. Balagadde
Journal: Blood
Blood (2022) 140 (Supplement 1): 8940–8941.
https://doi.org/10.1182/blood-2022-165982
Published: 2022
Journal Articles

The Impact of B-Cell-Directed Therapy on Sars-Cov-2 Vaccine Efficacy in CLL: 1-Year Follow up

Chaitra S. Ujjani, Christina Poh, Brian Tu, Sydney Lee, Stacy Selke, Haiying Zhu, Mazyar Shadman, Ryan C. Lynch, Meei-Li W Huang, Ajay K. Gopal, Edus H. Warren, Brian G. Till, Stephen D Smith, Amy Sperling, Joshua A. Hill, Philip Stevenson, Leslie Nielsen, Ted A. Gooley, Alexander L Greninger
Journal: Blood
Blood (2022) 140 (Supplement 1): 13222–13224.
https://doi.org/10.1182/blood-2022-170154
Published: 2022
Journal Articles

Circulating Tumor DNA in Untreated Classical Hodgkin Lymphoma Patients Treated with Pembrolizumab and Chemotherapy: Dynamic Response Assessment and Correlation with Baseline Metabolic Tumor Volume

Ryan C. Lynch, Stefan K. Alig, Chaitra S. Ujjani, Christina Poh, Edus H. Warren, Stephen D. Smith, Mazyar Shadman, Andrei Shustov, Brian G. Till, Vikram Raghunathan, Yolanda D. Tseng, Hilary Coye, Megan Shelby, Susan Ottemiller, Sarith Keo, Kaitlin Verni, Hongyan Du, Jacquelin Vandermeer, Ashley Gaston, Heather A. Rasmussen, Avanti Gulhane, Delphine Chen, Eric Wayne Dean, Paul S. Martin, Edmond A Marzbani, Jenna M. Voutsinas, Ash A. Alizadeh, Ajay K. Gopal
Journal: Blood
Blood (2022) 140 (Supplement 1): 6547–6549.
https://doi.org/10.1182/blood-2022-160234
Published: 2022
Journal Articles

Normalization of the Immune Microenvironment during Lenalidomide Maintenance Is Associated with Sustained MRD Negativity in Patients with Multiple Myeloma

David G. Coffey, Francesco Maura, Edgar Gonzalez-Kozlova, Javier Diaz-Mejia3, Ping Luo, Yong Zhang, Yuexin Xu, Edus H. Warren, Eric L Smith, Hearn Jay Cho, Alexander Lesokhin, Benjamin Diamond, Dickran Kazandjian, Trevor J. Pugh, Damian J. Green, Sacha Gnjatic, Ola Landgren
Journal: Blood
Blood (2021) 138 (Supplement 1): 329.
https://doi.org/10.1182/blood-2021-154506
Published: 2021
Journal Articles

Concurrent Pembrolizumab with AVD for Untreated Classical Hodgkin Lymphoma

Ryan C. Lynch, Chaitra S. Ujjani, Christina Poh, Edus H. Warren, Stephen D. Smith, Mazyar Shadman, Andrei R Shustov, Brian G. Till, Yolanda D. Tseng, Hilary Coye, Megan Shelby, Susan Ottemiller, Hongyan Du, Jacquelin Vandermeer, Heather A. Rasmussen, Stefan Alig, Ash A. Alizadeh, Avanti Gulhane, Delphine Chen, Eric Wayne Dean, Jason Lukas, Paul S. Martin, Edmond A Marzbani, Jenna Voutsinas, Ajay K Gopal
Journal: Blood
Blood (2021) 138 (Supplement 1): 233.
https://doi.org/10.1182/blood-2021-144610
Published: 2021
Journal Articles

Peripheral Blood Single-Cell Genotyping and Phenotyping in Multiple Myeloma Reveals Shared Mutations across Multiple Hematopoietic Cell Lineages

David G. Coffey, Aditi Agrawal, Maurizio Morri, Edus H. Warren, Robert Durruthy-Durruthy, Marc Arribas-Layton, Yue Wang, Norma F. Neff
Journal: Blood
Blood (2021) 138 (Supplement 1): 724.
https://doi.org/10.1182/blood-2021-154531
Published: 2021
Journal Articles

Safety and Efficacy of Third Generation CD20 Targeted CAR-T (MB-106) for Treatment of Relapsed/Refractory B-NHL and CLL

Mazyar Shadman, Cecilia Yeung, Mary Redman, Sang Yun Lee, Dong Hoon Lee, Susan Ra, Chaitra S. Ujjani, Bruce J. Dezube, Christina Poh, Edus H. Warren, Aude G. Chapuis, Damian J. Green, Andrew J. Cowan, Ryan D. Cassaday, Hans-Peter Kiem, Jordan Gauthier, Cameron J. Turtle, Ryan C. Lynch, Stephen D. Smith, Ajay K Gopal, David G. Maloney, Brian G. Till
Journal: Blood
Blood (2021) 138 (Supplement 1): 3872.
https://doi.org/10.1182/blood-2021-149181
Published: 2021
Journal Articles

Oral Ixazomib in Untreated Follicular Lymphoma Permits COVID-19 Vaccine Response and Its Efficacy Is Associated with Clinical Factors and Gene Expression Signatures

Solomon A. Graf, Ryan C. Lynch, Chaitra S. Ujjani, Ted A Gooley, David G. Coffey, Andrew J. Cowan, Stephen D. Smith, Mazyar Shadman, Edus H. Warren, Edward Libby, Colin D. Godwin, Alexander L Greninger, Jonathan R. Fromm, Ajay K Gopal
Journal: Blood
Blood (2021) 138 (Supplement 1): 1363.
https://doi.org/10.1182/blood-2021-153168
Published: 2021
Journal Articles

Ixazomib-Rituximab in Untreated Indolent B-NHL: An Effective, Very Low Toxicity Regimen

Solomon A. Graf, MD, Ryan C. Lynch, MD, Ted A Gooley, PhD, Chaitra S. Ujjani, MD, Peter Wilcox, Sabrina Wilcox, David G. Coffey, MD, Andrew J. Cowan, MD, Stephen D. Smith, MD, Mazyar Shadman, MDMPH, Edus H. Warren, MD PhD, Edward Libby, MD, Colin D. Godwin, MDMPhil, Ryan D. Cassaday, MD, Jonathan R. Fromm, MD PhD, Ajay K. Gopal, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4.
https://doi.org/10.1182/blood-2020-137226
Published: 2020
Journal Articles

Third Generation CD20 Targeted CAR T-Cell Therapy (MB-106) for Treatment of Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Mazyar Shadman, MDMPH, Cecilia Yeung, MD, Mary W Redman, PhD, Sang Yun Lee, PhD, Dong Hoon Lee, B.S., Ajeetha Ramachandran, PhD, Susan Ra, BS, Edmond A Marzbani, MD, Solomon A. Graf, MD, Edus H. Warren, MD PhD, Ajay K. Gopal, MD, Aude G. Chapuis, MD, Merav Bar, Damian J. Green, MD, Jordan Gauthier, MD MSc, Ryan D. Cassaday, MD, Hans-Peter Kiem, MD PhD, Cameron J. Turtle, MBBS, PhD, David G. Maloney, MD PhD, Brian G. Till, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-136440
Published: 2020
Journal Articles

Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma

Chaitra S. Ujjani, MD, Catherine Lai, MD MPH, Lori A. Leslie, MD, Pari Ramzi, RN, Ming Tan, Siyu Wang, Hongkun Wang, Eunice Shim, Nicole Swanson, Catherine M Broome, Ajay K. Gopal, MD, Stephen D. Smith, MD, Edus H. Warren, MD PhD, Katie Blue, Sabrina Kdiry, BSN, Brian G. Till, MD, Ryan C. Lynch, MD, Mazyar Shadman, MD MPH, Michael Johnson, Hilary Coye, PA-C, Megan Shelby, PA-C, Yolanda D. Tseng, MD, Andrei Shustov, MD, David G. Maloney, MD PhD, Bruce D. Cheson, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-136219
Published: 2020
Journal Articles

Dose-Dense Brentuximab Vedotin Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Is Highly Active for Second Line Treatment in Relapsed/Refractory Classical Hodgkin Lymphoma: Final Results of a Phase I/II Study

Ryan C. Lynch, MD, Ryan D. Cassaday, MD, Stephen D. Smith, MD, Jonathan R. Fromm, MD PhD, Andrew J. Cowan, MD, Edus H. Warren, MD PhD, Mazyar Shadman, MDMPH, Andrei R Shustov, MD, Brian G. Till, MD, Chaitra S. Ujjani, MD, Edward Libby, MD, Mary Philip, MDPhD, Hilary Coye, PA-C, Christen N. Martino, NP, Sandra Kanan, MSN, ARNP, Karolyn K. Morris, BA, Heather A. Rasmussen, BS, Sanaz Behnia, MD, Margaret E. Nartea, BS, Jenna M. Voutsinas, MPH, Ajay K. Gopal, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–18.
https://doi.org/10.1182/blood-2020-133763
Published: 2020
Journal Articles

High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic Trials

Manoj P. Menon, MD, Victor A. Chow, MD, Adam Greenbaum, MD PhD, Ryan C. Lynch, MD, Mazyar Shadman, MD MPH, Andrei Shustov, MD, Stephen D. Smith, MD, Brian G. Till, MD, Yolanda D. Tseng, MD, Chaitra S. Ujjani, MD, Thomas S. Uldrick, MD MS, Edus H. Warren, MD PhD, Ajay K. Gopal, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4733.
https://doi.org/10.1182/blood-2019-127505
Published: 2019
Journal Articles

A Pilot Trial of Adriamycin, Pembrolizumab, Vinblastine and Dacarbazine (APVD) for Patients with Untreated Classical Hodgkin Lymphoma

Ryan C. Lynch, MD, Chaitra S. Ujjani, MD, Edus H. Warren, MD PhD, David M. Kurtz, MD PhD, Hilary Coye, PA-C, Jacquelin Vandermeer, BS, Hongyan Du, MD, Adam Greenbaum, MD PhD, Ajay K. Gopal, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5299.
https://doi.org/10.1182/blood-2019-124997
Published: 2019
Journal Articles

High-Throughput Functional Drug Screening and Genomic Analysis to Guide Individualized Therapy for Relapsed/Refractory Multiple Myeloma

David G. Coffey, MD, Andrew J. Cowan, MD, Timothy S Martins, PhD, Damian J. Green, MD, Edward N. Libby, III, MD, Rebecca W. Silbermann, MD, Sylvia Chien, Jin Dai, PhD, Alicia Morales, Niall Curley, Bret Gary Degraaff, BS, Ted A Gooley, PhD, Edus H. Warren, MD PhD, Pamela S. Becker, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1885.
https://doi.org/10.1182/blood-2019-125383
Published: 2019